middle.news
Oklahoma Heart Institute Boosts Imricor’s VISABL-AFL Trial Momentum
9:06am on Tuesday 3rd of February, 2026 AEDT
•
Healthcare
Read Story
Oklahoma Heart Institute Boosts Imricor’s VISABL-AFL Trial Momentum
9:06am on Tuesday 3rd of February, 2026 AEDT
Key Points
Oklahoma Heart Institute joins VISABL-AFL trial as fourth U.S. site
Cardiology-owned MRI infrastructure at OHI expected to streamline trial operations
Patient recruitment acceleration supports faster FDA approval process
Procedures at OHI to commence in March 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imricor Medical Systems (ASX:IMR)
OPEN ARTICLE